Skip to Navigation
Skip to Main Content
Skip to Related Content
to view your mail
Yahoo Finance Plus
U.S. markets open in 5 hours 32 minutes
Russell 2000 Futures
Greenrose Acquisition Corp. (GNRSW)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 02:55PM EST
87 reactions on $GNRSW conversation
Sign in to post a message.
I bought GNRS when it was a SPAC shares and voted "NO" against the merger before the 10/27/2021 Special Meeting. I believe that after the merger my SPAC shares should be redeemed at the price of $10.00 per share because of my "NO" vote. I have had 1,000 GNRS shares in my FIRSTRADE SECURITIES, INC account but up to date I still saw the shares in my account, instead of the $10,000. When will my GNRS shares be redeemed? Or should I do something to get the redeem? Thanks!
Why are the warrants trading as if the merger is still doom to fail?
Well, with the completion of their first business agreement, we now know that green rose won't forfeit merger and return SPAC money.
This is great news and as you can see the warrants are now popping today, because they cannot expire worthless 👻
any news on why the stock is so low?
exact same situation with $ASLE , Financer back out they arranged new financing after heavy redemption and look at it now . That time Warrants went down to .50 cent and now it’s trading above $7.
In the event that the Corporation has not consummated an initial Business Combination by November 30, 2021 (the “Termination Date”), the Corporation shall (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter subject to lawfully available funds therefor, redeem 100% of the IPO Shares in consideration of a per-share price, payable in cash, equal to the quotient obtained by dividing (A) the aggregate amount then on deposit in the Trust Account, including interest (which shall be net of taxes payable), by (B) the total number of then outstanding IPO Shares, which redemption will completely extinguish rights of the holders of IPO Shares (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Board in accordance with applicable law, dissolve and liquidate, subject in each case to the Corporation’s obligations under the DGCL to provide for claims of creditors and other requirements of applicable law.
With the closing of the Business Combination, Greenrose currently expects to continue to work towards the acquisition of each of Shango Holdings, Inc. and Futureworks LLC (d/b/a The Health Center) and certain assets of Arizona-based True Harvest, LLC. Each of these acquisitions is subject to, among other things, Greenrose’s compliance with certain debt covenants, the terms, conditions and rights in each of the applicable agreements and the receipt of applicable state regulatory approvals, if any.
“Today marks an important milestone for Greenrose,” said Mickey Harley, CEO and Director of Greenrose. “Becoming a public company provides us with an opportunity to accelerate both our organic and M&A expansion plans as we work to build a platform of cannabis assets around award-winning, high-quality flower. We are grateful to our shareholders and our team for continuing to support us as we reach this exciting moment.”
The acquisition of Theraplant, LLC was funded, in part, by a $105 million senior secured credit facility from DXR Finance, LLC.
Business combination is completed ..
this half-a-despac has some numbers to show if they want to prove themselves right...so far, the numbers only from CT and a little of AZ...so maybe $60M total rev 2021?...big stretch...have to wait for a "real" filing...and they already screwed up the "old" ones!...refiled...but with Yalie engineers running company, what would you expect!...people educated/from CT!...ha!...
Sunstream on August 5, 2021 have not been satisfied and further notified the Company that Sunstream was not prepared to proceed with the proposed financing until such time as they are satisfied. In addition, on November 8, 2021, Sunstream waived the Company’s obligation to deal exclusively with Sunstream and indicated its support of the Company’s exploration of alternative financing sources. Sunstream also communicated its agreement to revisit financing opportunities at a future date, including on a co-lending basis. Greenrose is continuing to explore potential alternative financing options and commitments to further pursue consummation of its previously announced business combinations.
This is going to be Epic! Holding 20k warrants at .84
Can someone explain in plain english why people are buying this?
Greenrose Acquisition Corp. to Acquire Four Cannabis Companies, Creating a Vertically Integrated and Cash Flow Positive Platform Positioned for Significant Growth
The risk/reward on this is incredible
somebody knows something this is serious volume. almost more than the daily average in less than 10 minutes
Most underrated deal out their and warrants trading at fire-sale pricing
Either this is a sleeper or the managements asleep. If you are into speculation the risk reward is extremely high on the warrants. I am into speculation, but I have had my fill here. Holding for news. GLTA.
Back to 10, this is huge. Those who bought below ten for the guaranteed redemption can now cash out, making the likelihood of mas redemptions that could imperil the deal unlikely. Lets hope it stays above 10 and they can close the PIPE deal.
after the merger happens? what do you think it’ll be priced at?
Any rumors on who the target might be?
Mistakes with child tax credit, stimulus can trigger refund tax delays, IRS warns
The Fed aims to ‘avoid volatility at all costs,’ strategist says
Yahoo Finance Video
Super Bowl LVI: Shake Shack unveils Buffalo chicken sandwich, fries for big game
© 2022 Yahoo. All rights reserved.
About Our Ads
Discover new investment ideas by accessing unbiased, in-depth investment research